Evonik opened a new facility for GMP manufacturing of bioresorbable polymers and excipients for pharmaceutical and medical applications in Birmingham, AL.
Evonik opened a new facility for GMP manufacturing of bioresorbable polymers and excipients for pharmaceutical and medical applications in Birmingham, AL.
Evonik announced in a May 13, 2020 press release that it had commissioned a new GMP manufacturing facility in Birmingham, AL to support increased demand for the use of its Resomer bioresorbable polymers in parenteral drug products and implantable medical devices. With the expansion, Evonik will also begin to provide contract manufacturing organization (CMO) services for companies to outsource scale-up and commercial manufacturing of their own proprietary excipients.
The new, 2800-m2 facility is equipped with multiple cleanrooms, reactors, purification and micronization systems, and other ancillary equipment. The new site is adjacent to an existing CDMO facility that offers a range of formulation development and GMP-manufacturing services for parenteral drug products and application development and scale-up services for implantable medical devices. The facility is part of the Health Care business line, which is part of Evonik’s Nutrition & Care segment.
The company has harmonized the equipment and processes at the Birmingham facility with its other main biomaterials facility in Darmstadt, Germany, which allows the company to offer dual-sourcing to its customers for improved supply security.
Source: Evonik
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.